Talcum Powder Settlement Calculator
Estimate your payout from the Johnson & Johnson talc settlement
How much is the average talcum powder settlement? As of August 2026, J&J's most recent offer is approximately $5.5 billion, made in July 2026 and conditional on approval by 95% of claimants, with payments beginning in 2027. An earlier $8.9 billion bankruptcy plan was rejected by the courts in 2023.
July 2026 Update: J&J Proposes $5.5B Ovarian Talc Settlement
Johnson & Johnson proposed a $5.5 billion settlement on July 27, 2026 to resolve ovarian cancer talc claims. It is a proposal, not an approved settlement — there is no claims portal and no filing deadline yet.
See the full J&J talc settlement tracker →Johnson & Johnson Talcum Powder Settlement
$5.5B Settlement Fund
Est. 62,000 eligible claimants
Your Details
Your Estimated Payout
$1,344 — $2,016
Your Case Details
Answer a few questions to see your estimated range.
Higher-tier injuries qualify for higher settlement tiers.
Estimated Settlement Tier
$105,000 — $195,000
Mass tort settlements use injury-severity tiers. Most MDLs have published payment matrices — your tier depends on diagnosis + exposure proof.
Editorially Reviewed — Content reviewed for accuracy using published legal research, government data, and verified court records. See our methodology
Reviewed by Leonard Goldberg, Editor · Last updated
About the Talcum Powder Settlement
Johnson & Johnson faced over 62,000 lawsuits alleging that its talc-based products, including Johnson's Baby Powder and Shower to Shower, caused ovarian cancer and mesothelioma. Plaintiffs alleged that J&J knew for decades that its talcum powder products contained trace amounts of asbestos — a known carcinogen — and failed to warn consumers. Internal company documents revealed that J&J was aware of asbestos contamination as early as the 1970s.
After multiple jury verdicts awarding billions in damages — including a landmark $4.69 billion verdict for 22 women in Missouri and a $2.12 billion verdict in California — Johnson & Johnson proposed a $8.9 billion settlement through a subsidiary bankruptcy filing (LTL Management). The company has since discontinued talc-based baby powder in North America, switching to a cornstarch-based formula.
Our calculator estimates your potential payout based on the primary factors that determine claim value in talcum powder cases: your cancer diagnosis, the specific products used, duration of use, and your age at diagnosis. The settlement is structured in tiers based on disease severity and exposure evidence. See our methodology page for details on how we generate estimates.
Estimated Talcum Powder Settlement Tiers
| Claim Category | Estimated Range | Typical Profile |
|---|---|---|
| Tier 1 — Highest | $250,000 – $500,000 | Mesothelioma or death from ovarian cancer with documented long-term J&J talc use |
| Tier 2 — High | $100,000 – $250,000 | Ovarian cancer, 10+ years regular use of J&J talc products, strong documentation |
| Tier 3 — Moderate | $50,000 – $100,000 | Ovarian cancer, moderate usage history, some product documentation |
| Tier 4 — Lower | $10,000 – $50,000 | Other qualifying conditions, shorter usage period, limited documentation |
Estimates based on proposed J&J settlement tiers and comparable asbestos/talc litigation outcomes. Actual amounts depend on individual case factors and the final settlement structure.
Factors That Affect Your Talcum Powder Settlement
- Cancer Type: Mesothelioma claims receive the highest compensation because the only known cause of mesothelioma is asbestos exposure, creating a strong causal link. Ovarian cancer claims are also well-compensated, particularly when the cancer is advanced or resulted in death. Other cancers may qualify but typically receive lower amounts.
- Product Used: Claims involving Johnson's Baby Powder and Shower to Shower have the strongest evidence base because these products had the highest documented asbestos contamination. Other talc-based products may also qualify, but the specific J&J products have the most extensive litigation history and internal documentation proving the company's knowledge of contamination.
- Usage Duration: Longer duration of talcum powder use increases settlement value. Claimants who used talc products regularly for genital hygiene over many years have the strongest claims. Daily use over decades is associated with the highest tier settlements, while occasional or short-term use results in lower compensation.
- Age at Diagnosis: Age at diagnosis affects settlement value in two ways: younger plaintiffs who developed cancer may receive higher compensation due to greater impact on life expectancy, while older plaintiffs with longer usage histories may have stronger causation evidence. The most valuable claims typically involve women diagnosed between ages 40-65 who used talc products for 20+ years.
- Medical and Purchase Documentation: Strong medical records linking your cancer to talc/asbestos exposure and documentation of product purchase history significantly increase claim value. Treating physician statements, pathology reports showing talc particles in tissue samples, and receipts or affidavits confirming long-term J&J product use all strengthen the claim.
The J&J Talc Litigation: A Timeline of Discovery
The talcum powder litigation reveals one of the longest-running corporate cover-ups in US consumer product history. Understanding the timeline helps evaluate your case's strength.
- 1971 (Internal docs): J&J tests show asbestos contamination in talc mines. Internal memos discuss concerns but no consumer warnings issued.
- 1982: Dr. Daniel Cramer (Harvard) publishes first major peer-reviewed study linking genital talc use to ovarian cancer. J&J internal response: marketing continues unchanged, targeting African-American and Hispanic women for usage.
- 1990s: More epidemiological studies show ovarian cancer link. J&J's own industrial hygiene testing shows asbestos in products. Warnings discussed internally but rejected over marketing concerns.
- 2018: Reuters investigation publishes internal J&J documents showing decades of asbestos contamination knowledge. The New York Times follows with extensive coverage. Stock drops, litigation explodes.
- 2020: J&J discontinues talc-based baby powder in US/Canada, switching to cornstarch formulation. Company maintains products are safe but cites 'misinformation'.
- 2021: J&J creates LTL Management subsidiary via Texas two-step, transfers all talc liabilities, immediately files bankruptcy to halt individual lawsuits.
- 2022: Third Circuit dismisses first LTL bankruptcy as filed in bad faith, reviving individual lawsuits.
- 2023: J&J proposes $8.9B settlement through new LTL bankruptcy. Court again dismisses. Global talc sales discontinued.
- 2024-2025: J&J proposes a prepackaged bankruptcy with a $6.475B settlement for approximately 60,000 claimants; the court rejects it in March 2025. 2026: J&J returns to the tort system and offers approximately $5.5B in July 2026, requiring 95% claimant approval, with payouts from 2027.
The Texas Two-Step: J&J's Controversial Legal Maneuver
J&J has attempted to use Texas-specific corporate bankruptcy law to manage talc liabilities in ways that critics argue undermine legitimate claims. Understanding this maneuver helps you assess settlement value.
How the Texas two-step works
J&J (the profitable parent company) creates a new subsidiary called LTL Management under Texas law. Via 'divisional merger', J&J transfers ALL talc-related liabilities to LTL while keeping all assets. LTL Management immediately files Chapter 11 bankruptcy. Result: individual lawsuits are stayed (halted), and claimants must pursue recovery through bankruptcy proceedings rather than jury trials.
Why it's controversial
Critics argue this maneuver allows massively profitable companies to shield assets from legitimate injury claims. The parent company continues operating normally while claimants face delayed, reduced recoveries in bankruptcy. Both the 2021 and 2023 LTL bankruptcy filings were dismissed by federal courts as having been filed in bad faith specifically to delay and reduce talc liability.
Current status
After the March 2025 rejection of its $6.475B prepackaged bankruptcy, J&J abandoned the bankruptcy route. In July 2026 it offered approximately $5.5 billion to resolve claims in the tort system. The offer requires approval from 95% of claimants, and payments would begin in 2027. Status as of August 2026.
The Science: What Research Actually Shows
Understanding the scientific evidence helps you evaluate your case strength and what type of claim fits your situation:
Mesothelioma: The evidence is definitive — asbestos is the ONLY known cause. If you have mesothelioma and used J&J talc products (which historically contained asbestos), the causal link is essentially established. Mesothelioma talc cases have the highest settlement values ($500K+ typical).
Ovarian cancer: Multiple epidemiological studies show 20-40% increased risk with long-term genital talc use. Biological mechanism: talc particles applied to genitals can travel to ovaries, causing chronic inflammation over years. IARC classifies this as 'possibly carcinogenic' (Group 2B). Settlement strength depends on duration and frequency of use.
Other cancers (lung, uterine): Evidence is weaker. Some studies suggest connections but not with the strength of ovarian cancer or mesothelioma research. Settlement values are lower for these cancers.
IARC Classifications (critical legal evidence)
International Agency for Research on Cancer (IARC, part of WHO): Asbestos = Group 1 'carcinogenic to humans'. Genital use of talc = Group 2B 'possibly carcinogenic'. Asbestos-contaminated talc = Group 1. These classifications carry significant weight in court as the global standard for cancer causation evidence.
Frequently Asked Questions
Who qualifies for the talcum powder settlement?
Anyone who regularly used Johnson & Johnson talc-based products (primarily Johnson's Baby Powder or Shower to Shower) and was subsequently diagnosed with ovarian cancer, mesothelioma, or certain other cancers may be eligible. The settlement covers claims filed by individuals or on behalf of deceased family members. There is no minimum usage period, but longer and more regular use strengthens the claim.
How much is the average talcum powder settlement?
As of August 2026, J&J's most recent offer is approximately $5.5 billion, made in July 2026 and conditional on approval by 95% of claimants, with payments beginning in 2027. An earlier $8.9 billion bankruptcy plan was rejected by the courts in 2023. Average per-person payouts are expected to range from approximately $50,000 to $150,000, with mesothelioma cases and fatal ovarian cancer cases receiving significantly more (potentially $250,000 to $500,000). Individual payouts depend on the tier assignment based on cancer type, usage history, and evidence strength.
Is Johnson & Johnson still making talcum powder?
Johnson & Johnson discontinued its talc-based baby powder in the United States and Canada in 2020, switching to a cornstarch-based formula. The company stopped global sales of talc-based baby powder in 2023. J&J maintains that its talc products were safe but stated the discontinuation was a business decision due to declining sales from what it calls 'misinformation' about the product.
What is the connection between talcum powder and cancer?
Research has shown that talcum powder mined near asbestos deposits can be contaminated with asbestos fibers, a known carcinogen. Studies have also found that talc particles applied to the genital area can travel to the ovaries, where they cause chronic inflammation that may lead to cancer. The International Agency for Research on Cancer classifies genital use of talc as 'possibly carcinogenic to humans,' and asbestos-contaminated talc as 'carcinogenic to humans.'
How do I file a talcum powder claim?
Most talcum powder claims are filed through an attorney on a contingency fee basis (no upfront costs). An attorney will evaluate your medical records, usage history, and potential claim value, then file the appropriate paperwork. If the J&J settlement is approved, claims will be processed through the settlement trust. If you prefer not to join the settlement, you retain the right to file an individual lawsuit, though this is generally riskier and more time-consuming.
Can family members file on behalf of a deceased loved one?
Yes. If a family member died from ovarian cancer, mesothelioma, or another cancer linked to talcum powder use, surviving family members (typically the spouse, children, or estate representative) can file a wrongful death claim. These claims may receive higher compensation than living plaintiff claims, particularly in cases where the deceased used J&J talc products for many years before diagnosis.
What is the 'Texas two-step' bankruptcy and how does it affect my claim?
Johnson & Johnson attempted to use a Texas-specific corporate maneuver called a 'divisional merger' (colloquially the 'Texas two-step'). J&J created a subsidiary called LTL Management, transferred all talc-related liabilities to it, then immediately put LTL into bankruptcy. This tactic was intended to halt all individual lawsuits and channel all claims into a bankruptcy proceeding. Both LTL bankruptcies (2021 and 2023) were dismissed by federal courts as being filed in bad faith. J&J is now pursuing a proposed $6.475 billion settlement with prepackaged bankruptcy filings — legal developments continue and settlement terms may change.
How strong is the scientific evidence linking talcum powder to cancer?
Evidence varies by cancer type. Mesothelioma: very strong — asbestos (contaminant in talc) is the ONLY known cause. Ovarian cancer: stronger than decades past — multiple epidemiological studies show 20-40% increased risk with genital use. IARC classifies genital use of talc as 'possibly carcinogenic' (Group 2B) and asbestos-contaminated talc as 'carcinogenic to humans' (Group 1). J&J internal documents disclosed during litigation showed the company knew of asbestos contamination since the 1970s.
What documentation do I need to file a talcum powder claim?
Medical records showing your cancer diagnosis (pathology reports, oncologist records, surgical reports). Product use history (affidavits, receipts if available, product photos). Treating physician statement linking your cancer to talc exposure if available. Employment records (for occupational exposure claims). Autopsy reports for deceased family members. Your attorney will help gather these. Document everything immediately — some records become harder to obtain years later.
Should I join the settlement or pursue an individual lawsuit?
For most claimants, joining the settlement is the better option — faster resolution (months vs. years), guaranteed payment, less risk. For strong cases with rare circumstances (very young plaintiff, mesothelioma, unusually heavy exposure), an individual lawsuit can yield 3-10x more via jury verdict — but with delay and risk. Consult a talc-specialist attorney to evaluate: they can estimate settlement value vs. likely verdict range. Remember: J&J has lost 80%+ of talc trials that have gone to verdict.